Login / Signup

Amelioration of physicochemical, pharmaceutical, and pharmacokinetic properties of lornoxicam by cocrystallization with a novel coformer.

Kanwal FatimaNadeem Irfan BukhariSumaira LatifHafsa AfzalAmjad HussainRahat ShamimNasir Abbas
Published in: Drug development and industrial pharmacy (2021)
The study indicates that cocrystallization with DMU can concomitantly improve tabletability, dissolution rate, and in vivo performance of dissolution limited drug LORX.
Keyphrases
  • emergency department
  • drug induced